Maiwald in the press

Press Coverage

Royalty Pharma agrees to acquire Royalty Interest in Trelegy Ellipta from Theravance and Innoviva for $1.31 Billion and potential Milestones of $300 Million

• Further diversifies Royalty Pharma’s portfolio with market-leading respiratory therapy• Expected to significantly add to long-term Adjusted Cash Receipts growth (non-GAAP) NEW YORK, NY,...

Continue reading

Proxygen announces strategic collaboration with
Merck to develop molecular glue degraders

Proxygen, a leader in the discovery and development of molecular glue degraders, announced today that the company has entered into a strategic multi-year research collaboration and license agreement with Merck. Proxygen is eligible to receive up to €495 million ($554 milli...

Continue reading

Royalty Pharma acquires Royalty interest in Gavreto from Blueprint medicines for up to $340 Million

Attractive, precision oncology therapy with long patent duration added to portfolioBlueprint Medicines to receive $175 million upfront and $165 million in potential milestone payments

Continue reading

All press coverage

Maiwald press releases

Maiwald offers part of its office space to Munich volunteer organisation as a coordination hub for Ukrainian refugees

The patent attorneys’ firm of Maiwald has put part of its Munich office space at the disposal of the organisation “Münchner Freiwillige – Wir helfen e.V.” to use as a contact point for refugees fleeing Ukraine. From rooms in Elisenhof, located very close to...

Continue reading

Video Conference Without Consent of the Parties – Amicus Curiae Brief Filed in Connection With Case G 1/21 Before the Enlarged Board of Appeal of the EPO

Maiwald, together with other leading patent law firms, considers video conferencing without the consent of the parties to be inadmissible and has filed an amicus curiae brief in connection with the proceedings G 1/21 before the Enlarged Board of Appeal of the Europea...

Continue reading

Maiwald establishes practice for patent litigation in the field of standard-essential HEVC patents and video codec technologies against non-practicing entities

Maiwald is setting up a patent litigation team with partner Dr Simon Lud and two associates. Maiwald is mandated by Unified Patents, LLC, located in the USA.

Continue reading

All press releases

Press Contact

Dr Eva Dörner


German Patent Attorney

European Patent Attorney